Display options
Cite
Tamrakar M, Kharel P, Traeger A, et al. Completeness and quality of low back pain prevalence data in the Global Burden of Disease Study 2017. BMJ Glob Health. 2021;6(5)doi: 10.1136/bmjgh-2021-005847.
Tamrakar, M., Kharel, P., Traeger, A., Maher, C., O'Keeffe, M., & Ferreira, G. (2021). Completeness and quality of low back pain prevalence data in the Global Burden of Disease Study 2017. BMJ global health, 6(5), . https://doi.org/10.1136/bmjgh-2021-005847
Tamrakar, Mamata, et al. "Completeness and quality of low back pain prevalence data in the Global Burden of Disease Study 2017." BMJ global health vol. 6,5 (2021). doi: https://doi.org/10.1136/bmjgh-2021-005847
Tamrakar M, Kharel P, Traeger A, Maher C, O'Keeffe M, Ferreira G. Completeness and quality of low back pain prevalence data in the Global Burden of Disease Study 2017. BMJ Glob Health. 2021 May;6(5). doi: 10.1136/bmjgh-2021-005847. PMID: 34001521; PMCID: PMC8130740.
Copy Download .nbib Format: NLM
Share it on

BMJ Glob Health. 2021 May;6(5). doi: 10.1136/bmjgh-2021-005847.

Completeness and quality of low back pain prevalence data in the Global Burden of Disease Study 2017.

BMJ global health

Mamata Tamrakar, Priti Kharel, Adrian Traeger, Chris Maher, Mary O'Keeffe, Giovanni Ferreira

Affiliations

  1. Institute for Musculoskeletal Health, The University of Sydney, Sydney, New South Wales, Australia.
  2. Institute for Musculoskeletal Health, The University of Sydney, Sydney, New South Wales, Australia [email protected].

PMID: 34001521 PMCID: PMC8130740 DOI: 10.1136/bmjgh-2021-005847

Abstract

INTRODUCTION: Completeness of Global Burden of Disease (GBD) Study data is acknowledged as a limitation. To date, no study has evaluated this issue for low back pain, a leading contributor to disease burden globally.

METHODS: We retrieved reports, in any language, based on citation details from the GBD 2017 study website. Pairs of raters independently extracted the following data: number of prevalence reports tallied across countries, age groups, gender and years from 1987 to 2017. We also considered if studies enrolled a representative sample and/or used an acceptable measure of low back pain.

RESULTS: We retrieved 488 country-level reports that provide prevalence data for 103 of 204 countries (50.5%), with most prevalence reports (61%) being for high-income countries. Only 16 countries (7.8%) have prevalence reports for each of the three decades of the GBD. Most of the reports (79%) did not use an acceptable measure of low back pain when estimating prevalence.

CONCLUSION: We found incomplete coverage across countries and time, and limitations in the primary prevalence studies included in the GBD 2017 study. This means there is considerable uncertainty about GBD estimates of low back pain prevalence and the disease burden metrics derived from prevalence.

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Keywords: arthritis; indices of health and disease and standardisation of rates; public Health

Conflict of interest statement

Competing interests: AT reports he has received research grants from numerous Government and not for profit agencies outside the submitted work. CM reports he has received research grants from numerou

References

  1. Lancet. 2020 Oct 17;396(10258):1135-1159 - PubMed
  2. Lancet Glob Health. 2015 Nov;3(11):e712-23 - PubMed
  3. Rheumatology (Oxford). 2021 Jan 25;: - PubMed
  4. BMC Musculoskelet Disord. 2018 Aug 16;19(1):292 - PubMed
  5. Ann Transl Med. 2020 Mar;8(6):299 - PubMed
  6. Eur J Pain. 2010 Aug;14(7):747.e1-7 - PubMed
  7. Lancet. 2018 Jun 9;391(10137):2356-2367 - PubMed
  8. Lancet. 2018 Nov 10;392(10159):1859-1922 - PubMed
  9. Lancet. 2018 Jun 9;391(10137):2384-2388 - PubMed
  10. Lancet. 2020 Oct 17;396(10258):1204-1222 - PubMed

MeSH terms

Publication Types